Results•11 min read•Updated 2025-08-22

Tirzepatide Week 8: What to Expect, Weight Loss & Tips

Tirzepatide week 8 guide covering expected weight loss, side effects at the 5 mg dose, diet and exercise tips, and how your results compare to SURMOUNT trial data.

Written by Trimi Medical Team. Medically reviewed by Dr. Amanda Foster, MD. This guide provides week-specific information for patients on tirzepatide therapy. Content is updated regularly to reflect the latest clinical evidence and patient outcomes.

Quick links: Tirzepatide treatment, semaglutide treatment, and tirzepatide weight loss results.

What Happens During Week 8 of Tirzepatide?

Week 8 completes your second month on tirzepatide and your final week at 5 mg before a potential increase to 7.5 mg. By now, cumulative weight loss of 10 to 15 pounds is achievable for many patients, representing approximately 6 to 10 percent of starting body weight. This is an important checkpoint to evaluate with your provider. Discuss your progress, any lingering side effects, and your comfort level before deciding on the next dose increase. Some patients may remain at 5 mg if results are strong and side effects are minimal.

At the 5 mg dose during the first dose increase, tirzepatide is providing stronger activation of both GLP-1 and GIP pathways, resulting in more pronounced appetite suppression and improved metabolic function. The medication works by mimicking both the GLP-1 and GIP hormones naturally produced in your gut, reducing hunger, slowing gastric emptying, and improving how your body processes glucose and stores fat.

If you are looking for information about week 7 or week 9, visit those guides for week-specific details. For a complete overview of what tirzepatide can achieve, see our guide on how much weight you can lose on tirzepatide.

Expected Weight Loss at Week 8

By week 8 of tirzepatide treatment at the 5 mg dose, patients typically experience cumulative weight loss of 8-15 lbs. This represents approximately 6-10% of starting body weight for most patients, though individual results can vary significantly based on factors including starting weight, metabolic rate, dietary adherence, physical activity level, and genetic factors that influence how your body responds to GLP-1 receptor agonist therapy.

The SURMOUNT-1 trial showed that patients on the 5 mg dose of tirzepatide achieved significant weight loss compared to placebo, with many participants seeing 5 to 10 percent body weight reduction within the first two months. The dual incretin mechanism at this dose level produces more robust appetite suppression than GLP-1-only medications like semaglutide at comparable timepoints in treatment.

Week 8 Weight Loss Snapshot

Dose: 5 mg | Typical cumulative loss: 8-15 lbs | Body weight reduction: 6-10% | Phase: First Dose Increase

For context on how these results compare to other GLP-1 medications, see our detailed tirzepatide vs semaglutide comparison. Tirzepatide consistently outperforms semaglutide in clinical trials due to its dual mechanism of action, and this advantage is evident even at week 8 of treatment.

Side Effects at Week 8

Moving to 5 mg often triggers a temporary return of side effects similar to what you experienced when first starting. Nausea may be more pronounced for the first few days after the dose increase, and some patients report more noticeable appetite suppression that borders on food aversion. Diarrhea or constipation can occur as your digestive system adjusts. These effects typically peak in the first 3 to 5 days after the dose increase and then stabilize.

Nausea: Common and typically most pronounced in the first 2-3 days after injection or dose increase

Appetite suppression: Strong and consistent, representing a fundamental shift in your hunger patterns

Gastrointestinal changes: Constipation, diarrhea, or bloating may occur as your digestive system adjusts to slowed gastric emptying

Injection site reactions: Mild redness or slight discomfort at the injection site that typically resolves within a day

Headache: Some patients experience mild headaches, especially during dose increases, that respond to over-the-counter pain relievers

For a comprehensive overview of all potential side effects, read our complete guide on tirzepatide side effects. If you experience severe or persistent symptoms, contact your healthcare provider promptly.

Appetite and Food Changes at Week 8

Appetite suppression at 5 mg is noticeably stronger than at 2.5 mg. Many patients report that they can go significantly longer between meals without feeling hungry, and that food no longer occupies their thoughts the way it used to. This is the dose where many patients first describe feeling a fundamental shift in their relationship with food.

Understanding how tirzepatide affects your appetite is key to maximizing your results. Unlike stimulant-based weight loss medications that create jittery energy, tirzepatide works through your body's natural hormone signaling pathways. The GLP-1 receptor activation slows gastric emptying, making you feel fuller longer after meals, while the GIP receptor activation improves your body's ability to process nutrients efficiently. Together, these mechanisms create a sustainable reduction in caloric intake without the feeling of deprivation that characterizes most diets.

At week 8, many patients describe the reduction in food noise — that persistent mental chatter about what to eat, when to eat, and how much to eat — as beginning to quiet down, with noticeably fewer intrusive food thoughts throughout the day. This psychological benefit is often cited as one of the most transformative aspects of GLP-1 therapy.

Diet Tips for Week 8

With stronger appetite suppression, there is a risk of eating too little. Ensure you are still consuming at least 1200 calories daily for women and 1500 for men to maintain adequate nutrition. Prioritize nutrient-dense foods since you are eating less overall — vegetables, lean proteins, whole grains, and healthy fats. Consider a daily multivitamin to cover any nutritional gaps.

Prioritize protein at every meal — aim for at least 25 grams per meal to preserve lean muscle mass during weight loss

Eat slowly and mindfully, taking at least 20 minutes per meal to allow your brain to register fullness signals

Stay hydrated with at least 64 ounces of water daily, sipping throughout the day rather than drinking large amounts at once

Avoid high-fat fried foods and heavy sauces that can worsen nausea and gastrointestinal side effects

Include fiber-rich vegetables and whole grains to support digestive health and maintain regular bowel movements

Plan meals in advance to ensure you are eating nutritious foods even when appetite is low

For a deeper look at the complete GLP-1 treatment guide, including nutritional strategies optimized for patients on tirzepatide and semaglutide, visit our comprehensive resource. Proper nutrition significantly impacts both the rate and sustainability of your weight loss results.

Exercise Recommendations for Week 8

Increase your activity to include 30 to 45 minutes of moderate exercise most days. Walking, swimming, cycling, or light resistance training are excellent choices. As your weight decreases, exercise becomes easier and more enjoyable. Adding light strength training now helps preserve muscle mass during weight loss.

Physical activity during week 8 of tirzepatide treatment serves multiple purposes beyond accelerating weight loss. Regular exercise helps preserve lean muscle mass, which is critical during any period of significant weight reduction. Muscle preservation maintains your metabolic rate, improves body composition, and ensures that the weight you lose is predominantly fat rather than muscle tissue. Additionally, exercise improves cardiovascular health, enhances insulin sensitivity, boosts mood through endorphin release, and supports better sleep quality.

During these early weeks, listen to your body carefully. Some patients feel mildly nauseous after exercise, particularly on injection days. If this occurs, try scheduling your workouts for the day before your injection or two to three days after, when medication-related nausea is typically at its lowest.

SURMOUNT Trial Data: Week 8 Context

The SURMOUNT-1 trial, published in the New England Journal of Medicine, enrolled 2,539 adults with obesity or overweight with at least one weight-related comorbidity. Participants were randomized to receive tirzepatide at 5 mg, 10 mg, or 15 mg, or placebo. The trial ran for 72 weeks and demonstrated that all tirzepatide dose groups achieved statistically significant and clinically meaningful weight loss compared to placebo. The results established tirzepatide as the most effective GLP-1 based weight loss medication in clinical use.

At week 8, your results should be evaluated in the context of these clinical benchmarks. If your weight loss is tracking at or above the trial averages, you are responding well to treatment. If your results are below expectations, discuss with your provider whether dose adjustment, dietary modifications, or additional interventions might help optimize your outcome. For detailed tirzepatide weight loss results across all dose levels, see our comprehensive analysis.

Getting Tirzepatide at $125 Per Month

One of the biggest barriers to tirzepatide therapy is cost. Brand-name Zepbound and Mounjaro can cost over $1,000 per month without insurance. Trimi offers compounded tirzepatide starting at $125 per month, making this life-changing medication accessible to patients who might otherwise be unable to afford treatment.

Trimi's pricing includes the medication, provider consultations, ongoing medical oversight, and free shipping — no hidden fees, no consultation charges, and no long-term contracts. You can start, adjust, or cancel your treatment at any time. Every prescription is evaluated by board-certified providers who specialize in weight management and metabolic health, ensuring you receive expert guidance throughout your treatment journey.

For patients at week 8 who are considering starting treatment or switching providers, Trimi offers a straightforward path to affordable tirzepatide therapy. Visit our best GLP-1 provider guide to compare your options and find the right fit for your weight loss goals.

Tips for Success at Week 8

Stay consistent with your injection schedule, diet, and exercise even as early excitement fades into routine

Track your progress with weekly weigh-ins taken at the same time under the same conditions for accuracy

Take progress photos monthly — the mirror and scale do not always reflect the full extent of your transformation

Communicate openly with your provider about any side effects, concerns, or questions about your treatment plan

Connect with a community of other tirzepatide patients for support, motivation, and shared experience

Keep a food journal to identify patterns in what triggers nausea and what foods you tolerate well

Get adequate sleep of 7 to 9 hours per night, which supports both weight loss and overall recovery

Frequently Asked Questions

How much weight should I lose by week 8 of tirzepatide?

By week 8 of tirzepatide treatment at the 5 mg dose, most patients have lost approximately 8-15 lbs from their starting weight, which typically represents 6-10% of total body weight. Individual results vary based on starting weight, diet, exercise, and metabolic factors. The SURMOUNT clinical trials showed consistent weight loss at this stage of treatment, though some patients may lose more or less than the average.

What are the common side effects at week 8 on tirzepatide?

At week 8 on the 5 mg dose, common side effects include stronger but manageable gastrointestinal effects including nausea, decreased appetite, and occasional diarrhea. Most patients find that side effects are present but improving as the body adapts. If you experience severe or persistent side effects, contact your healthcare provider for guidance on managing symptoms or adjusting your treatment plan.

Should I increase my tirzepatide dose after week 8?

Dose escalation decisions at week 8 should be made in consultation with your healthcare provider based on your individual response, side effect tolerance, and weight loss goals. Your provider may recommend increasing to 7.5 mg if you have tolerated 5 mg well and want to optimize weight loss. Never adjust your dose without medical guidance.

What should I eat during week 8 of tirzepatide?

During week 8 on tirzepatide, your nutritional strategy should emphasize quality and consistency. With stronger appetite suppression, there is a risk of eating too little. Ensure you are still consuming at least 1200 calories daily for women and 1500 for men to maintain adequate nutrition. Prioritize nutrient-dense foods since you are eating less overall — vegetables, lean proteins, whole grains, and healthy fats. Consider a daily multivitamin to cover any nutritional gaps. The reduced appetite caused by tirzepatide means every calorie counts more, so prioritize nutrient-dense whole foods including lean proteins, vegetables, fruits, and whole grains. Avoid high-fat and high-sugar processed foods which can worsen gastrointestinal side effects. Stay well-hydrated with at least 64 ounces of water daily, as proper hydration supports both weight loss and side effect management.

Is it normal to hit a weight loss plateau at week 8?

Weight loss plateaus in the first 8 weeks are relatively uncommon since the medication is still building in your system and your body is adjusting to the initial caloric deficit. If your weight stalls briefly, continue your routine and it should resume within a few days.

Can I exercise during week 8 of tirzepatide treatment?

Absolutely. Exercise during week 8 of tirzepatide is encouraged and enhances your results. Increase your activity to include 30 to 45 minutes of moderate exercise most days. Walking, swimming, cycling, or light resistance training are excellent choices. As your weight decreases, exercise becomes easier and more enjoyable. Adding light strength training now helps preserve muscle mass during weight loss. Listen to your body and adjust intensity based on how you feel, especially on injection days when nausea may be more noticeable. Regular physical activity not only accelerates weight loss but also helps preserve lean muscle mass, improves cardiovascular health, boosts mood, and supports long-term weight maintenance after treatment.

How does week 8 on tirzepatide compare to semaglutide?

At week 8, tirzepatide typically produces greater weight loss than semaglutide at a comparable timepoint. Clinical trial data from the SURMOUNT trials for tirzepatide and the STEP trials for semaglutide show that tirzepatide patients lose approximately 20 to 25 percent more total body weight on average. This advantage comes from tirzepatide's dual mechanism of action, targeting both GLP-1 and GIP receptors, compared to semaglutide which targets only GLP-1. However, individual responses vary and some patients may respond better to one medication over the other.

Sources & References

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Individual results vary significantly based on starting weight, metabolic factors, diet, exercise, and medication adherence. Always consult a qualified healthcare provider before starting, adjusting, or discontinuing any medication. The weight loss figures cited are based on clinical trial averages and may not reflect your individual experience. Trimi provides compounded tirzepatide — this is not a review of brand-name Zepbound or Mounjaro.

Tirzepatide Week 8: What to Expect, Weight Loss & Tips

More on Tirzepatide Timeline

Tirzepatide Week 7

Tirzepatide Week 9

Tirzepatide Weight Loss Results

How Much Weight Can You Lose on Tirzepatide